Mark J. Osborn
Impact in
- Aging top 5%
Papers in
-
- CRISPR and Genetic Engineering 26
- Pluripotent Stem Cells Research 9
- RNA Interference and Gene Delivery 8
- Genetics 21
- Virus-based gene therapy research 16
- Co-authors
- Jakub Tolar (43 shared papers)Bruce R. Blazar (31 shared papers)David R. Liu (9 shared papers)Gregory A. Newby (4 shared papers)Amber McElroy (15 shared papers)John E. Wagner (13 shared papers)Megan Riddle (16 shared papers)Lily Xia (10 shared papers)
- Journals
- Molecular Therapy (8 papers)Blood (7 papers)International Journal of Molecular Sciences (6 papers)Journal of Investigative Dermatology (6 papers)Cell (3 papers)
- Partner nations
- United StatesUnited KingdomSouth Korea
In The Last Decade
Mark J. Osborn
69 papers receiving 4.3k citations
Mark J. Osborn's Hit Papers
Peers
Comparison fields: 5 of 129
- Business and International Management 145
- Aging 85
- Cell Biology 644
- Molecular Biology 2.6k
- Genetics 896
Countries citing papers authored by Mark J. Osborn
This map shows the geographic impact of Mark J. Osborn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark J. Osborn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark J. Osborn more than expected).
Fields of papers citing papers by Mark J. Osborn
This network shows the impact of papers produced by Mark J. Osborn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark J. Osborn. The network helps show where Mark J. Osborn may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark J. Osborn, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 73 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Enhanced prime editing systems by manipulating cellular determinants of editing outcomes Hit paper breakdown → | 2021 | 514 |
| 2 | Engineered virus-like particles for efficient in vivo delivery of therapeutic proteins Hit paper breakdown → | 2022 | 426 |
| 3 | 2008 | 408 | |
| 4 | 2010 | 266 | |
| 5 | 2013 | 204 | |
| 6 | Phage-assisted evolution and protein engineering yield compact, efficient prime editors Hit paper breakdown → | 2023 | 182 |
| 7 | 2018 | 172 | |
| 8 | Evolution of an adenine base editor into a small, efficient cytosine base editor with low off-target activity Hit paper breakdown → | 2022 | 169 |
| 9 | 2019 | 160 | |
| 10 | 2008 | 125 | |
| 11 | 2010 | 119 | |
| 12 | 2014 | 93 | |
| 13 | Efficient site-specific integration of large genes in mammalian cells via continuously evolved recombinases and prime editing Hit paper breakdown → | 2024 | 91 |
| 14 | 2012 | 88 | |
| 15 | 2016 | 82 | |
| 16 | 2010 | 78 | |
| 17 | 2019 | 77 | |
| 18 | 2013 | 64 | |
| 19 | 2010 | 63 | |
| 20 | 2015 | 56 |
About Mark J. Osborn
Mark J. Osborn is a scholar working on Molecular Biology, Genetics, Cell Biology, Oncology and Immunology, having authored 73 papers that have together received 4.3k indexed citations. Recurring topics across this work include CRISPR and Genetic Engineering (26 papers), Virus-based gene therapy research (16 papers), Skin and Cellular Biology Research (13 papers), Pluripotent Stem Cells Research (9 papers), RNA Interference and Gene Delivery (8 papers), CAR-T cell therapy research (8 papers), Autoimmune Bullous Skin Diseases (6 papers) and Lysosomal Storage Disorders Research (5 papers). The work is most often cited by research in Business and International Management (145 citations), Aging (85 citations), Cell Biology (644 citations), Molecular Biology (2.6k citations) and Genetics (896 citations). Mark J. Osborn has collaborated with scholars based in United States, United Kingdom and South Korea. Frequent co-authors include Jakub Tolar, Bruce R. Blazar, David R. Liu, Gregory A. Newby, Amber McElroy, John E. Wagner, Megan Riddle, Lily Xia, Ron McElmurry and Beau R. Webber. Their work appears in journals such as Molecular Therapy, Blood, International Journal of Molecular Sciences, Journal of Investigative Dermatology and Cell.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.